Recent developments in CD19-targeted therapies for follicular lymphoma
{{output}}
Introduction: CD19 has emerged as an important and novel therapeutic target in follicular lymphoma. CD19-directed therapies, including monoclonal antibodies, bispecific antibodies, and CAR T-cell therapies, offer promising avenue... ...
